A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

NCT01325558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Malignant Neoplasm
Malignant Solid Tumour

Interventions

BIOLOGICAL: ALT-836 in combination with gemcitabine

Sponsor

Altor BioScience